BBS4 p.Lys358fs
c.1072_1073del · rs2065896039 · VCV866549
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 13 of 16 |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP 0.84 | GERP 1.4, phastCons 1 |
| Overall | ||
| CADD | 31.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,468 |
| South Asiangrpmax | 0.0011% | 91,082 |
| European (non-Finnish) | 0.00102% | 98,317 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BBS4
- Protein
- p.Lys358fs
- Coding
- c.1072_1073del
- MANE Select
- NM_033028
- dbSNP
- rs2065896039
- Type
- Deletion
- Location
- chr15:72735148 (GRCh38)
- Gene constraint
- LOEUF 0.953 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 78.36 · 1 PDB
- Residue 358
- the 'required for localization to centrosomes' region
Disease context
Bardet-Biedl syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Bardet-Biedl syndrome 4
For Bardet-Biedl syndrome (Orphanet):
- Inheritance
- Autosomal recessive, Oligogenic
- Onset
- Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Specific population)
Similar variants
- BBS4 p.Lys358Arg Uncertain significance ★★ ⚠ same residue
- BBS4 p.Lys358Gln Uncertain significance ★ ⚠ same residue
- BBS4 p.Lys358= Likely benign ★ same residue
- BBS4 c.1064_1106+97del Pathogenic/Likely pathogenic ★★ same condition
- BBS4 p.Ala467fs Likely pathogenic ★★ same condition
- BBS4 p.Glu432fs Pathogenic/Likely pathogenic ★★ same condition
- BBS4 p.Leu114fs Pathogenic/Likely pathogenic ★★ same condition
- BBS4 p.Leu310fs Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bbs4-p-lys358fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown